Rare diseases
Investigational molecules
Locations
A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome
CzechiaA study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
BulgariaA study testing cagrilintide and semaglutide combination for kidney damage in people with chronic kidney disease and type 2 diabetes who are overweight or obese
FranceTesting Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned
DenmarkA Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis
CzechiaA study testing aprepitant gel for treating skin rash in cancer patients receiving epidermal growth factor receptor inhibitor therapy
HungaryA study testing SPY072 compared to placebo in adults with moderately to severely active rheumatologic disease
BulgariaA Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies
FranceA Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
GermanyA study to test if tibulizumab works and is safe for adults with systemic sclerosis
HungaryA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
BulgariaA Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
